Active, Not Recruiting
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients
NCT05114421
- Conditions
- High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Peritoneal High Grade Serous Adenocarcinoma, +3 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States